GoodRx Holdings, Inc. (GDRX)

Nasdaq · Common Stock · Services-Computer Processing & Data Preparation

One email a week from me: what it filed, which 13F holders added or cut, where its scores stand. Free.

American prescription drug price tracking website and app

Corporate structure

15 entities across 3 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-02-26 — see the exhibit.

Which other public companies file entities in the same places:

Subsidiaries of GoodRx Holdings, Inc. as disclosed in its SEC filing
Entity	Jurisdiction	Note
GoodRx Intermediate Holdings, LLC	Delaware
GoodRx, Inc.	Delaware
Iodine, Inc.	Delaware
GoodRx Care, LLC FKA HeyDoctor, LLC	Delaware
Lighthouse Acquisition Corp.	Delaware
Scriptcycle, LLC	North Carolina
HealthiNation Inc.	Delaware
RxSaver, Inc.	Delaware
Buckeye Acquisition, LLC DBA RxNXT	Delaware
flipMD, Inc.	Delaware
Pharmacy Services, LLC	Delaware
VitaCare Prescription Services, Inc.	Florida
VCRx Acquisition, LLC	Delaware
ScriptDrop Acquisition, LLC	Delaware
Project Cannon, LLC	Delaware

Financial health

Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.

Piotroski F-score

6 / 8

PASSReturn on assets positiveROA 2.2%
PASSOperating cash flow positiveOCF 168M
PASSReturn on assets improving1.2% → 2.2%
PASSCash flow exceeds earningsOCF 168M vs NI 30M
PASSLong-term debt ratio falling35.1% → 34.4% of assets
FAILCurrent ratio improving5.32 → 2.61
PASSNo share dilution392M → 357M shares
FAILGross margin improvingno gross profit reported
FAILAsset turnover improving0.57× → 0.57×

Six-year record

Year	Revenue	Net income	Free cash flow	Gross margin	Shares
FY2020	$550.7M	−$293.6M	$110.8M	—	274,696,000
FY2021	$745.4M	−$25.3M	$174.2M	—	409,981,000
FY2022	$766.6M	−$32.8M	$142.8M	—	412,858,000
FY2023	$750.3M	−$8.9M	$137.2M	—	410,315,000
FY2024	$792.3M	$16.4M	$182.7M	—	392,172,000
FY2025	$796.9M	$30.4M	$164.4M	—	356,973,000

Ownership flow

1 institutions tracked — 1 added, 0 reduced.

Institutional holders of GoodRx Holdings, Inc. and their share-count change
Manager	Kind	Shares	Change	Value
GEODE CAPITAL MANAGEMENT, LLC	Index	1,171,369	+93,242	$3.4M

From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.

Capital returned

What the company actually paid out and bought back, as reported — the record behind any yield figure.

Shares repurchased

2026Q1: $12.6M
2025Q1: $99.9M
2024Q1: $153.2M
2023Q1: $9.5M
2022Q1: $83.8M
2021Q1: $0

Identity

CIK: 0001809519
LEI: 529900ATKYECI45EHV09
FIGI: BBG00X0VP8D9
SIC: 7374 · Services-Computer Processing & Data Preparation
Incorporated: DE
Headquarters: SANTA MONICA, CA
Founded: 2011-09-00

Ownership

Institutional: 55.8%
Institutions: 210
Insiders: 12.7%

Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.

Other services-computer processing & data preparation companies

GoodRx Holdings, Inc. files under SIC 7374 — all 21 services-computer processing & data preparation companies compared on assets and F-score.

AUTOMATIC DATA PROCESSING INCADP Workday, Inc.WDAY DXC Technology CoDXC CLARIVATE PLCCLVT FIRST ADVANTAGE CORPFA Reddit, Inc.RDDT

Questions about GoodRx Holdings, Inc.

How many subsidiaries does GoodRx Holdings, Inc. file with the SEC?: 15, listed in its most recent exhibit 21. They are incorporated across 3 jurisdictions (Delaware, North Carolina, Florida). That exhibit is filed with the company's annual report and is the company's own list, not an estimate.
Is GoodRx Holdings, Inc. financially healthy?: GoodRx Holdings, Inc. scores 6 out of 8 on the Piotroski F-score. Only 8 of the nine tests could be computed from what it filed; the rest need a prior year it has not reported. Every test and the numbers behind it are shown above, so the arithmetic is checkable rather than something you have to take on trust.
Who are the largest institutional holders of GoodRx Holdings, Inc.?: Among the managers tracked here, the biggest positions as of the 2026-Q2 13F filings are GEODE CAPITAL MANAGEMENT, LLC (adding). Direction is the change in share count against that manager's own previous filing; managers with no prior filing are left out rather than counted as new buyers.

This page is one panel of the terminal

The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.

Download the terminal See pricing

Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.

Corporate structure

15 entities across 3 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-02-26 — see the exhibit.

Which other public companies file entities in the same places:

Delaware13 North Carolina1 Florida1

Entity

Jurisdiction

Note

GoodRx Intermediate Holdings, LLC

Delaware

GoodRx, Inc.

Delaware

Iodine, Inc.

Delaware

GoodRx Care, LLC FKA HeyDoctor, LLC

Delaware

Lighthouse Acquisition Corp.

Delaware

Scriptcycle, LLC

North Carolina

HealthiNation Inc.

Delaware

RxSaver, Inc.

Delaware

Buckeye Acquisition, LLC DBA RxNXT

Delaware

flipMD, Inc.

Delaware

Pharmacy Services, LLC

Delaware

VitaCare Prescription Services, Inc.

Florida

VCRx Acquisition, LLC

Delaware

ScriptDrop Acquisition, LLC

Delaware

Project Cannon, LLC

Delaware

Financial health

Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.

Piotroski F-score

6 / 8

PASSReturn on assets positiveROA 2.2%
PASSOperating cash flow positiveOCF 168M
PASSReturn on assets improving1.2% → 2.2%
PASSCash flow exceeds earningsOCF 168M vs NI 30M
PASSLong-term debt ratio falling35.1% → 34.4% of assets
FAILCurrent ratio improving5.32 → 2.61
PASSNo share dilution392M → 357M shares
FAILGross margin improvingno gross profit reported
FAILAsset turnover improving0.57× → 0.57×

Six-year record

Year	Revenue	Net income	Free cash flow	Gross margin	Shares
FY2020	$550.7M	−$293.6M	$110.8M	—	274,696,000
FY2021	$745.4M	−$25.3M	$174.2M	—	409,981,000
FY2022	$766.6M	−$32.8M	$142.8M	—	412,858,000
FY2023	$750.3M	−$8.9M	$137.2M	—	410,315,000
FY2024	$792.3M	$16.4M	$182.7M	—	392,172,000
FY2025	$796.9M	$30.4M	$164.4M	—	356,973,000

Ownership flow

1 institutions tracked — 1 added, 0 reduced.

Institutional holders of GoodRx Holdings, Inc. and their share-count change
Manager	Kind	Shares	Change	Value
GEODE CAPITAL MANAGEMENT, LLC	Index	1,171,369	+93,242	$3.4M

Questions about GoodRx Holdings, Inc.

How many subsidiaries does GoodRx Holdings, Inc. file with the SEC?

15, listed in its most recent exhibit 21. They are incorporated across 3 jurisdictions (Delaware, North Carolina, Florida). That exhibit is filed with the company's annual report and is the company's own list, not an estimate.

Is GoodRx Holdings, Inc. financially healthy?

GoodRx Holdings, Inc. scores 6 out of 8 on the Piotroski F-score. Only 8 of the nine tests could be computed from what it filed; the rest need a prior year it has not reported. Every test and the numbers behind it are shown above, so the arithmetic is checkable rather than something you have to take on trust.

Who are the largest institutional holders of GoodRx Holdings, Inc.?

Among the managers tracked here, the biggest positions as of the 2026-Q2 13F filings are GEODE CAPITAL MANAGEMENT, LLC (adding). Direction is the change in share count against that manager's own previous filing; managers with no prior filing are left out rather than counted as new buyers.